Cases 21 - 30 of 146
Novartis Pharmaceuticals Corporation v. Dr. Reddy's Laboratories Inc. et al
as 1:2022cv00498
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Dr. Reddy's Laboratories Ltd. et al
as 1:2022cv00298
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ANACOR PHARMACEUTICALS, INC. et al v. DR. REDDYS LABORATORIES, LTD. et al
as 3:2021cv17831
Plaintiff:
ANACOR PHARMACEUTICALS, INC. and PF PRISM IMB B.V.
Defendant:
DR. REDDYS LABORATORIES, LTD. and DR. REDDYS LABORATORIES, INC.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2021cv01349
Plaintiff:
Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V.
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Anacor Pharmaceuticals, LLC, et al., v. Dr. Reddys Laboratories, Ltd., et al.,
as 1:2021cv01348
Plaintiff:
Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. and Anacor Pharmaceuticals, LLC
Defendant:
Alkem Laboratories Ltd., Dr. Reddys Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2021cv01330
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alkem Laboratories Ltd., Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271
NOVARTIS PHARMACEUTICALS CORPORATION et al v. DR. REDDY'S LABORATORIES INC. et al
as 3:2021cv14428
Plaintiff:
NOVARTIS PHARMACEUTICALS CORPORATION and DANA-FARBER CANCER INSTITUTE, INC.
Defendant:
DR. REDDY'S LABORATORIES INC. and DR. REDDY'S LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Dr. Reddys Laboratories, Inc. et al
as 1:2021cv01106
Plaintiff:
Novartis Pharmaceuticals Corporation and Dana-Farber Cancer Institute, Inc.
Defendant:
Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Dr. Reddys Laboratories, Inc. et al
as 1:2021cv01033
Plaintiff:
Merck Sharp & Dohme Corp.
Defendant:
Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
